glp-1 doctor san francisco New study explores treatment for stimulant addiction Younan Nowzaradan, aka Dr. Now
Description
Twelve patients meeting the New York Heart Association class III/IV heart failure classification were given a 5-week infusion of GLP-1 and the results were compared to 9 patients receiving standard therapy
GLP-1 drugs accelerate weight reduction, sometimes causing a temporary spike in uric acid concentration within the bloodstream
Time runs along the horizontal axis (typically in weeks)
doi: 10.1111/dme.14287
The approval of Gazyva offers a more effective and potentially convenient treatment optionafter four initial doses in the first year, it can be given twice yearly
S2CID 6471940
